Last reviewed · How we verify

NCT02644785

Investigation of Anaphylactic Reaction in Cases Undergoing Cardiac By-Pass Surgery

Completed Last updated 21 March 2017
What this trial tests

trial testing protamine in Protamine Allergy in 30 participants. Completed in 1 February 2016.

Timeline
1 January 2016
Primary endpoint
1 February 2016
1 February 2016

Quick facts

Lead sponsorMustafa Kemal University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date1 January 2016
Primary completion1 February 2016
Estimated completion1 February 2016
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mustafa Kemal University

Who can join

19 and older, any sex, with Protamine Allergy or Protamine Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The investigators aim to assess tryptase test efficacy for measuring the allergic response to protamine during cardiac bypass surgery. Additionally, the investigators aim to establish a differential diagnosis on the basis of potential allergens or clinical causes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mustafa Kemal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02644785.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing